NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
December 07 2023 - 4:30PM
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)
("NeuroOne" or the "Company"), a medical technology company focused
on improving surgical care options and outcomes for patients
suffering from neurological disorders, will host a conference call
to discuss financial results for its fourth quarter and fiscal year
ended September 30, 2023, and provide a corporate update, on
December 14, 2023 at 5:00 PM Eastern Time.
Conference Call and Webcast
Information:
Thursday, December 14, 2023 – 5:00 PM Eastern
Time
Participant Dial-In:877-405-1216 / +1
201-689-8336
Live Webcast: Join
here.
Phone Replay: 877-660-6853 /
201-612-7415Available through December 28, 2023
Webcast Replay:Available for 12 months
About NeuroOne
NeuroOne Medical Technologies Corporation is a
developmental stage company committed to providing minimally
invasive and hi-definition solutions for EEG recording, brain
stimulation and ablation solutions for patients suffering from
epilepsy, Parkinson's disease, dystonia, essential tremors, chronic
pain due to failed back surgeries, and other related neurological
disorders that may improve patient outcomes and reduce procedural
costs. The Company may also pursue applications for other areas
such as depression, mood disorders, pain, incontinence, high blood
pressure, and artificial intelligence. For more information,
visit nmtc1.com.
Contact:
800-631-4030 ir@nmtc1.com
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Apr 2024 to May 2024
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From May 2023 to May 2024